AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Innovative RNA Interference Treatment for Hypertension
Discusses a new RNA interference treatment for mild to moderate hypertension administered every six months, showing promising results in lowering blood pressure. Explores combination approaches at ACC and the potential of drugs like Ola Parsirin and Lippa Disserin in reducing LP Little A levels for improved cardiac outcomes.